Clinical Trial Update: Tucaresol As Add-On To HAART (Highly Active Antiretroviral Therapy) In Chronic HIV-1 Infected Adults [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Tucaresol as an add-on to HAART in adults with chronic HIV-1 infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Tucaresol (tucaresol)

Snippet

Sponsor: GlaxoSmithKline | Conditions: HIV Infection | Phase 2 | Status: COMPLETED